Brief: Mesoblast Anticipate To Incur Significant Losses For Foreseeable Future
27/08/2026 02:32
BRIEF-Mesoblast Anticipate To Incur Significant Losses For Foreseeable Future Aug 27 (Reuters) - Mesoblast Limited MSB.AX:
ANTICIPATE THAT WE MAY CONTINUE TO INCUR SIGNIFICANT LOSSES FOR FORESEEABLE FUTURE
THERE CAN BE NO ASSURANCE THAT WE WILL EVER ACHIEVE OR MAINTAIN PROFITABILITY
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil